Skip to content

Prognostic impact of systematic lymphadenectomy during interval debulking surgery after neoadjuvant chemotherapy in stage III ovarian cancer: A 38-institution retrospective cohort study using inverse probability of treatment weighting.

Sep 2026 · European Journal of Surgical Oncology · Vol 52 11, pp. 112121 · 0 citations · 30 references
Medicine

TL;DR

SyLND was associated with better PFS and OS in patients with stage III ovarian cancer undergoing IDS, and pre-NACT nodal assessment may help determine the indications for SyLND during IDS.

Abstract

INTRODUCTION We evaluated the clinical significance of systematic lymph node dissection (SyLND) during interval debulking surgery (IDS) in patients with stage III ovarian cancer, focusing on subgroups that might benefit from SyLND.

Methods

The multicenter retrospective study included patients with FIGO stage III ovarian, fallopian tube, and primary peritoneal cancers, who underwent IDS following neoadjuvant chemotherapy (NACT), at Gynecologic Cancer Study Group of the Japan Clinical Oncology Group (JCOG-GCSG) institutions between 2017 and 2021. Patients were classified into SyLND and no/selective lymph node dissection (NoLND/SeLND) groups. Progression-free survival (PFS) was the primary outcome, and overall survival (OS) and postoperative complications were secondary outcomes. Inverse probability of treatment weighting was applied.

Results

Among 696 eligible patients, SyLND was associated with better PFS (hazard ratio [HR] 0.73, 95% confidence interval [CI] 0.55-0.97) and OS (HR 0.66, 95% CI 0.48-0.92) than NoLND/SeLND. In subgroup analyses of patients achieving complete resection, SyLND yielded no survival advantage in those with clinical-negative nodes (cN0). Conversely, among patients with clinical-positive nodes (cN1) before NACT, PFS and OS favored SyLND, although differences were not statistically significant. Similar trends were observed in cN1 patients whose lymph nodes decreased to <10 mm before IDS. SyLND was associated with higher complication rates.

Conclusion

SyLND was associated with better PFS and OS in patients with stage III ovarian cancer undergoing IDS. Exploratory subgroup analyses suggested only a favorable but statistically inconclusive trend in patients with cN1. Pre-NACT nodal assessment may help determine the indications for SyLND during IDS.

View source

Similar papers

Open access Sep 2026

Lymphadenectomy During Interval Debulking Surgery in Advanced Epithelial Ovarian Cancer: A Multicenter Real-World Study

Objective To investigate the controversial impact of lymphadenectomy on prognosis and postoperative complications in patients with advanced epithelial ovarian cancer (AEOC) receiving neoadjuvant chemotherapy followed by interval debulking surgery (IDS). Methods This retrospective real-world study analyzed 1068 patients...

Xing-Yu Liu, Yi-Yang Shen, Ying-Jun Zhao et al. · 0 citations
Open access Sep 2026

Therapeutic outcomes and prognostic determinants of neoadjuvant chemotherapy plus interval debulking surgery compared with primary debulking surgery in advanced-stage epithelial ovarian cancer

Objective To compare the therapeutic outcomes of neoadjuvant chemotherapy followed by interval debulking surgery (NACT-IDS) and primary debulking surgery (PDS) in patients with advanced epithelial ovarian cancer (AEOC) and to evaluate factors associated with prognosis. Methods This retrospective study included 97 patie...

Yan Ma, Meng-Li Xu, Qi Zhang et al. · 0 citations
Open access Jul 2026

Association of regional lymph node resection with survival in patients with locally advanced-stage cervical cancer: A retrospective SEER-based cohort study

Objective This study aimed to validate the prognostic discriminatory power of the revised International Federation of Gynecology and Obstetrics (FIGO) 2018 staging system and to evaluate the association between regional lymph node resection (RLNR) and survival in cervical cancer (CC) patients who underwent RLNR followe...

Ai-Yuan Wu, R. Rezhake, Zi-Yin Huang et al. · 0 citations
Open access Sep 2026

The role of lymphadenectomy in surgical management of malignant ovarian germ cell tumors: a multi-center retrospective cohort study with inverse propensity of treatment weighting.

It was indicated that LND was not associated with a survival benefit but increased surgical morbidity in patients with malignant ovarian germ cell tumors, underscoring the critical importance of timely chemotherapy.

Xin-Yang Jin, Jia-Xin Yang, Ke-Zhen Zhang et al. · 0 citations
Open access 2026

Survival outcomes, treatment response, and prognostic factors of different treatment modalities in patients with epithelial ovarian cancer: a retrospective cohort study.

PDS and NACT+IDS offer comparable survival outcomes in patients with advanced EOC, whereas NACT+IDS is associated with improved perioperative safety and higher tumor response rates without increasing severe chemotherapy-related toxicity.

Yong-Hui Zou, Yan-Qiu Wang, Ming-Jun Fan et al. · 0 citations
Open access Oct 2026

Comparative effectiveness of neoadjuvant treatment strategies and predictors of pathological complete response in locally advanced esophageal squamous cell carcinoma: a real-world retrospective cohort study

Objective To compare pathological complete response (pCR) across different neoadjuvant treatment strategies in patients with locally advanced esophageal squamous cell carcinoma (ESCC) and to identify clinicopathological factors associated with pCR. Methods In this single-center retrospective cohort study, 247 consecuti...

Xiao-Li Yuan, Yu-Ying Liang, T. Han et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.